Evidence map›Paper›PMID 28409271›Full record

ArticleJournal of inherited metabolic disease2017

Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency.

S Balasubramaniam, L G Riley, D Bratkovic, D Ketteridge, N Manton, M J Cowley, V Gayevskiy, T Roscioli, M Mohamed, T Gardeitchik and 2 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of inherited metabolic disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. The Physiological and Pathological Role of Acyl-CoA Oxidation.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. The diagnostic utility of genome sequencing in a pediatric cohort with suspected mitochondrial disease.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Biomarkers for Detecting Mitochondrial Disorders.Journal of clinical medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 3 countries.

S BalasubramaniamWestern Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia. shanti.balasubramaniam@health.nsw.gov.au.
L G RileyDiscipline of Paediatrics & Child Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
D BratkovicMetabolic Unit, SA Pathology, Women's and Children's Hospital, North Adelaide, 5006, SA, Australia.
D KetteridgeMetabolic Unit, SA Pathology, Women's and Children's Hospital, North Adelaide, 5006, SA, Australia.
N MantonDepartment of Surgical Pathology, SA Pathology, Women's and Children's Hospital, North Adelaide, 5006, SA, Australia.
M J CowleyKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
V GayevskiyKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
T RoscioliKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
M MohamedInstitute for Genetic and Metabolic Disease, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands.
T GardeitchikInstitute for Genetic and Metabolic Disease, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands.
E MoravaInstitute for Genetic and Metabolic Disease, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands.
J ChristodoulouWestern Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia.
Garvan Institute of Medical Research · AURadboud University Nijmegen · NLWomen's and Children's Hospital · AUChildren's Hospital at Westmead · AUSouth Australia Pathology · AUTulane Medical Center · USUniversity of Melbourne · AUUniversity of Sydney · AUUNSW Sydney · AU

Funding

Netherlands Organisation for Scientific Research 017.008.052NHMRC project grant 1026891
6 · The paper itself

Abstract

Clinical finding of cutis laxa, characterized by wrinkled, redundant, sagging, nonelastic skin, is of growing significance due to its occurrence in several different inborn errors of metabolism (IEM). Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade. Here, we further expand the list of inborn errors of metabolism associated with cutis laxa by describing the clinical presentation of a 17-month-old girl with Leigh-like syndrome due to enoyl coenzyme A hydratase, short chain, 1, mitochondria (ECHS1) deficiency, a mitochondrial matrix enzyme that catalyzes the second step of the beta-oxidation spiral of fatty acids and plays an important role in amino acid catabolism, particularly valine.

Indexed as

Cutis LaxaEnoyl-CoA HydrataseFemaleHumansInfantLeigh DiseaseProto-Oncogene MasECHS1 protein, humanEnoyl-CoA HydrataseMAS1 protein, humanProto-Oncogene MasCompound Heterozygous VariantCutis LaxaMitochondrial Matrix EnzymeRespiratory Chain Enzyme ActivityTransaldolase

Identifiers

PMID28409271
OpenAlexW2606184351

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.